South & Central America Vascular Closure Device Market Forecast to 2030
South & Central America Vascular Closure Device Market Forecast to 2030 – Regional Analysis – by Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology, and Endovascular Surgery), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Prevalence of Cardiovascular Diseases Fuels the South & Central America Vascular Closure Device Market
Cardiovascular diseases such as atherosclerosis, angina pectoris, and acute myocardial infarction are the major causes of mortality in the world. As per data provided by the World Health Organization (WHO), cardiovascular diseases cause nearly 17.9 million deaths every year, which makes it a leading cause of mortality among all noncommunicable diseases, followed by cancer, chronic respiratory diseases, and diabetes (including deaths associated with renal disorders). According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and ∼24% of cardiovascular-related deaths are associated with high low-density lipoprotein (LDL) levels. Vascular closure devices (VCDs) offer a new way to enhance patients’ comfort and ambulation after invasive cardiovascular treatments via femoral arterial access. Vascular closure devices are used in different therapeutic approaches to provide easy, quick, and reliable hemostasis. In the US, femoral arterial access is the most often used vascular access technique for percutaneous coronary intervention (PCI) and coronary angiography. Nevertheless, there has been an increase in traction toward cardiac catheterization and percutaneous coronary intervention (PCI) via radial access in recent years. Several femoral artery closure devices have been developed to shorten vascular closure times, with variable rates of vascular complications observed in clinical trials. Vascular closure devices (VCDs) have emerged as an effective alternative to traditional mechanical compression procedures performed after cardiac catheterization. VCDs reduce the time of hospital stays, speed up patient mobilization and shorten the time needed to achieve hemostasis. Thus, the South & Central America vascular closure device market is growing notably with the increasing prevalence of cardiovascular diseases.
South & Central America Vascular Closure Device Market Overview
Brazil has a proactive medical device industry, and it is the largest of all Latin American countries. According to the International Trade Administration (US Department of Commerce), the medical device industry in Brazil relies mainly on the US, China, and Germany. In 2021, the country reported an increase of 7.3% in the imports of medical devices, reaching the value of US$ 6.2 billion. Per the “Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities” study published in August 2022 in AHA Journals, the prevalence of CVDs in Brazil has increased by 26.8% over the past three decades. Moreover, in 2019, the age-standardized rate (ASR) of CVD prevalence was 5,454, and incidence was 475 per 100,000 inhabitants. Thus, the increasing cardiovascular disease incidence provides lucrative opportunities for the vascular closure devices market in Brazil.
South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Vascular Closure Device Market Segmentation
The South & Central America vascular closure device market is segmented based on product type, access, procedure, end user, and country.
Based on product type, the South & Central America vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.
By access, the South & Central America vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.
By procedure, the South & Central America vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.
In terms of end-use industry, the South & Central America vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.
Based on country, the South & Central America vascular closure device market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America vascular closure device market in 2022.
Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the South & Central America vascular closure device market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the South & Central America vascular closure device market was valued at US$ 86.24 million in 2022 and is expected to reach US$ 144.86 million by 2030, registering a CAGR of 6.7% from 2022 to 2030. Burgeoning demand for minimally invasive devices and increasing prevalence of cardiovascular diseases are among the critical factors attributed to the South & Central America vascular closure device market expansion.
Improvements in medical science and technologies have given way to minimally invasive devices, which can aid in the replacement of traditional painful surgical methods by minimally invasive or noninvasive methods. Minimally invasive techniques have gained popularity in surgical fields such as cardiac surgery. Many of these procedures are performed using femoral cannulation for extracorporeal circulation. Vascular closure devices have gained popularity as they reduce the invasiveness and supersede surgical cut-down to cannulate the femoral artery. Vascular closure devices are mainly used in transcatheter and endovascular interventions to enable wound healing and reduce procedure time.
Angiography is one of the common procedures performed in a wide variety of specialties, including vascular surgery, interventional radiology, and diagnostic and interventional cardiology. Vascular closure devices are useful in the settings of a large body habitus, anticoagulation, and antiplatelet therapies. They are also used in cases where extended bed rest may not be desirable (such as a patient with extensive pressure ulcers). A vascular closure device with resorbable collagen material, which eliminates the use of suture materials, has been introduced for transfemoral transcatheter aortic valve implantation (TAVI). For instance, the MANTA device by Teleflex Medical Inc. is adequate for the closure of arterial access sites of up to 25 Fr. Safety and efficacy of the system were demonstrated in a real-world TAVI patient cohort. Thus, the increasing demand for minimally invasive devices drives the vascular closure devices market growth.
On the contrary, risk of infection related to vascular closure devices hampers the growth South & Central America vascular closure device market.
Based on product type, the South & Central America vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held 70.9% share of the South & Central America vascular closure device market in 2022, amassing US$ 61.14 million. It is projected to garner US$ 103.92 million by 2030 to expand at 6.9% CAGR during 2022-2030. The active approximators segment is further bifurcated into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.
By access, the South & Central America vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held 77.4% share of the South & Central America vascular closure device market in 2022, amassing US$ 66.76 million. It is projected to garner US$ 111.32 million by 2030 to expand at 6.6% CAGR during 2022-2030.
By procedure, the South & Central America vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology segment held 62.7% share of the South & Central America vascular closure device market in 2022, amassing US$ 54.08 million. It is projected to garner US$ 90.12 million by 2030 to expand at 6.6% CAGR during 2022-2030.
In terms of end-use industry, the South & Central America vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held 58.7% share of South & Central America vascular closure device market in 2022, amassing US$ 50.59 million. It is projected to garner US$ 84.95 million by 2030 to expand at 6.7% CAGR during 2022-2030.
Based on country, the South & Central America vascular closure device market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held 51.4% share of South & Central America vascular closure device market in 2022, amassing US$ 44.36 million. It is projected to garner US$ 75.70 million by 2030 to expand at 6.9% CAGR during 2022-2030.
Key players operating in the South & Central America vascular closure device market are Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America vascular closure device market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the vascular closure device market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Vascular Closure Device Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Cardiovascular Diseases
4.1.2 Burgeoning Demand for Minimally Invasive Devices
4.2 Market Restraints
4.2.1 Risk of Infection Related to Vascular Closure Devices
4.3 Market Opportunities
4.3.1 Untapped Potential of Emerging Economies
4.4 Future Trends
4.4.1 Strategic Activities by Manufacturers
4.5 Impact Analysis:
5. Vascular Closure Device Market – South & Central America Market Analysis
5.1 South & Central America Vascular Closure Device Market Revenue (US$ Mn), 2022 – 2030
6. South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 South & Central America Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 Active Approximators
6.3.1 Overview
6.3.2 Active Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Active Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Passive Approximators
6.4.1 Overview
6.4.2 Passive Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Passive Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.5 External Hemostatic Devices
6.5.1 Overview
6.5.2 External Hemostatic Devices: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 – by Access
7.1 Overview
7.2 South & Central America Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
7.3 Femoral Access
7.3.1 Overview
7.3.2 Femoral Access: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Radial Access
7.4.1 Overview
7.4.2 Radial Access: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 – by Procedure
8.1 Overview
8.2 South & Central America Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
8.3 Interventional Cardiology
8.3.1 Overview
8.3.2 Interventional Cardiology: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Interventional Radiology
8.4.1 Overview
8.4.2 Interventional Radiology: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Endovascular Surgical
8.5.1 Overview
8.5.2 Endovascular Surgical: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 – by End Users
9.1 Overview
9.2 South & Central America Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Center
9.4.1 Overview
9.4.2 Ambulatory Surgical Center: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Vascular Closure Device Market – Country Analysis
10.1.1.1 South & Central America Vascular Closure Device Market by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.2.3.1 Brazil: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.2.4 Brazil South & Central America Vascular Closure Device Market, by Access
10.1.1.2.5 Brazil: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.2.6 Brazil: South & Central America Vascular Closure Device Market, by End Users
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.3.3.1 Argentina: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Vascular Closure Device Market, by Access
10.1.1.3.5 Argentina: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.3.6 Argentina: South & Central America Vascular Closure Device Market, by End Users
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Product Type
10.1.1.4.3.1 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Access
10.1.1.4.5 Rest of South & Central America: South & Central America Vascular Closure Device Market, by Procedure
10.1.1.4.6 Rest of South & Central America: South & Central America Vascular Closure Device Market, by End Users
11. South & Central America Vascular Closure Device Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Vascular Closure Devices Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cordis Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Haemonetics Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Becton Dickinson and Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cardinal Health Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Teleflex Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 2. Brazil: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Product Type
Table 3. Brazil: South & Central America Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Access
Table 6. Brazil: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Procedure
Table 7. Brazil: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – End Users
Table 8. Argentina: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Product Type
Table 9. Argentina: South & Central America Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: South & Central America Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Access
Table 12. Argentina: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Procedure
Table 13. Argentina: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – End Users
Table 14. Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Product Type
Table 15. Rest of South & Central America: South & Central America Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Access
Table 18. Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – Procedure
Table 19. Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn) – End Users
Table 20. Recent Inorganic Growth Strategies in the Vascular Closure Devices Market
Table 21. Recent Organic Growth Strategies in the Vascular Closure Devices Market
Table 22. Glossary of Terms, South & Central America Vascular Closure Device Market
Â
LIST OF FIGURES
Figure 2. South & Central America Vascular Closure Device Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Vascular Closure Device Market Revenue (US$ Mn), 2020 – 2030
Figure 5. South & Central America Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
Figure 6. Active Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Passive Approximators: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. External hemostatic devices: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
Figure 10. Femoral Access: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Radial Access: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
Figure 13. Interventional Cardiology: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ceramic: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Endovascular Surgical: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
Figure 17. Hospitals: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Center: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: South & Central America Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Vascular Closure Device Market, By Geography, 2022 ($Mn)
Figure 21. South & Central America Vascular Closure Device Market, By Key Countries, 2022 And 2030 (%)
Figure 22. Brazil: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 23. Argentina: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. Rest of South & Central America: South & Central America Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Vascular Closure Devices Market
1. Abbott Laboratories
2. Becton Dickinson and Co
3. Cardinal Health Inc
4. Cordis Corp
5. Haemonetics Corp
6. Medtronic Plc
7. Teleflex Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.